Viewing Study NCT00718666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:17 PM
Ignite Modification Date: 2026-01-29 @ 5:37 PM
Study NCT ID: NCT00718666
Status: COMPLETED
Last Update Posted: 2019-06-26
First Post: 2008-07-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infections, Meningococcal View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None Vaccines, conjugate View
None Immunogenicity View
None Meningococcal vaccine View
None Booster vaccination View
None Primary vaccination View
None Neisseria meningitides View
None Toddlers View
None Humans View
None Meningococcal disease View